BPC-157 and MOTS-c have both been flagged by the FDA for potential safety concerns, and both appear on WADAs list of banned substances (the organization that oversees drug testing in competitive sports)
If recovery poses your bottleneck, prioritize proven recovery strategies such as programming, sleep, nutrition, stress management, and physical therapy first
Cytoprotective properties: Research has demonstrated that BPC may serve as a useful cytoprotective peptide therapy in heart disturbances, myocardial infarction, and heart failure (6)
If the symptoms do not improve in 5 to 15 minutes, or they come back, use a second pen if the person has one
hospitalization required Maintenance of Remission: Immunomodulators (azathioprine, 6-MP, methotrexate) for steroid-dependent or frequently-relapsing disease Biologic monotherapy or combination therapy (biologic + immunomodulator) for moderate-to-severe disease Step-up or top-down approach based on disease severity, patient risk factors, and prior therapy Biologic Therapy Targets: TNF-: Infliximab (IV), adalimumab (SC), certolizumab pegol (SC) IL-12/23: Ustekinumab (IV induction, SC maintenance) Integrin: Vedolizumab (IV) IL-23: Risankizumab (IV induction, SC maintenance) JAK inhibition: Upadacitinib (oral) Surgical Management Surgery is indicated in approximately 7080% of patients with Crohns disease over their lifetime, per StatPearls
This method provides immediate bioavailability and higher blood levels than oral supplements, supporting energy production, nervous system function, and overall cellular health
.jpg)
